7 Year Results of a Prospective Randomized Study of Alemtuzumab Vs Rabbit Anti-Thymocyte Globulin Induction in Kidney and Kidney Pancreas Transplantation.

被引：0
|
作者：
Farney, A. [1 ]
Rogers, J. [1 ]
Doares, W. [1 ]
Iskandar, S. [1 ]
Orlando, G. [1 ]
Adams, P. [1 ]
Gautreaux, M. [1 ]
Kaczmorski, S. [1 ]
Stratta, R. [1 ]
机构：
[1] Wake Forest Baptist Hlth, Winston Salem, NC USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2014年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
1364
引用
收藏
页码：90 / 90
页数：1
相关论文
共 50 条
  • [31] Low dose anti-thymocyte globulin compared to basiliximab induction therapy in pediatric kidney transplantation.
    Baron, PW
    Ojogho, O
    Sahney, S
    Ben-Youssef, R
    Cutler, D
    Weissman, J
    Franco, E
    Zuppan, C
    Concepcion, W
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 496 - 496
  • [32] Comparison of Anti-Thymocyte Globulin and Alemtuzumab as Induction Therapy in Older Kidney Transplant Recipients
    Chaung, M.
    Hollinger, E.
    Brokhof, M.
    Alvey, N.
    Lineberger, L.
    Kenyon, N.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 916 - 916
  • [33] 5-Year Results of a Prospective, Randomized, Single-Center Study of Alemtuzumab Compared With Rabbit Antithymocyte Globulin Induction in Simultaneous Kidney-Pancreas Transplantation
    Stratta, R. J.
    Rogers, J.
    Orlando, G.
    Farooq, U.
    Al-Shraideh, Y.
    Farney, A. C.
    [J]. TRANSPLANTATION PROCEEDINGS, 2014, 46 (06) : 1928 - 1931
  • [34] Efficacy of Early Steroid Withdrawal with Anti-Thymocyte Globulin Induction - Optimal Dose of Anti-Thymocyte Globulin in Korean Kidney Transplantation -
    Park, J. B.
    Chng, Y. S.
    Kim, Y. H.
    Song, K. B.
    Jung, J. H.
    Kim, S-C
    Han, D. J.
    [J]. TRANSPLANTATION, 2012, 94 (10) : 989 - 989
  • [35] Prospective, Randomized, Single-Center Trial of Alemtuzumab vs. Rabbit Anti-Thymocyte Globulin Induction in Renal and Pancreas Transplant: Infectious Complications Update.
    Doares, William
    Ashcraft, Elizabeth
    Singh, Rajinder
    Hart, Lois
    Farney, Alan
    Hartmann, Erica
    Reeves-Daniel, Amber
    Rogers, Jeff
    Adams, Patricia
    Stratta, Robert
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 282 - 283
  • [36] A prospective randomized single center trial of alemtuzumab versus rabbit anti-thymocyte induction in renal and pancreas transplantation: Infectious complications.
    Ashcraft, E.
    Farney, A.
    Moore, P.
    Hartmann, E.
    Rogers, J.
    Doares, W.
    Hart, L.
    Adams, P.
    Stratta, R.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 234 - 234
  • [37] The Results after Induction of Rabbit Anti-Thymocyte Globulin (rATG) in the Deceased Donor Kidney Transplantation Using the Expanded Criteria Donor
    Moon, Ju Ik
    Choi, In Seok
    [J]. TRANSPLANTATION, 2018, 102 : S35 - S35
  • [38] Timing of Rabbit Anti-Thymocyte Globulin Induction Therapy: Is There an Impact on Kidney Transplant Outcomes?
    Harrison, J.
    Hamandi, B.
    Li, Y.
    Famure, O.
    Kim, S. J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 254 - 254
  • [39] Comparison of basiliximab to rabbit anti-thymocyte globulin induction in kidney transplant recipients.
    Ahmad, I
    Ketel, B
    Barone, G
    Barri, Y
    Reed, K
    Almquist, G
    Abulezz, S
    [J]. TRANSPLANTATION, 2000, 69 (08) : S159 - S159
  • [40] Alemtuzumab and Minimization Immunotherapy in Kidney Transplantation: Long-Term Results of Comparison With Rabbit Anti-Thymocyte Globulin and Standard Triple Maintenance Therapy
    Zachariah, M.
    Nader, N. D.
    Brar, J.
    Singh, N.
    Venuto, R.
    Patel, S.
    Said, M.
    Laftavi, M. R.
    Pankewycz, O.
    [J]. TRANSPLANTATION PROCEEDINGS, 2014, 46 (01) : 94 - 100
12345